PCS-2023 > 3 > 3E > 3E0 > 3E0N |
3E0 | Physiological Systems and Anatomical Regions, Introduction | |
Info: | Introduction: Putting in or on a therapeutic, diagnostic, nutritional, physiological, or prophylactic substance except blood or blood products | |
3E0N | Introduction, Male Reproductive | |
3E0N3 | Percutaneous | |
3E0N30 | Antineoplastic | |
3E0N304 | Introduction of Liquid Brachytherapy Radioisotope into Male Reproductive, Percutaneous Approach | |
3E0N305 | Introduction of Other Antineoplastic into Male Reproductive, Percutaneous Approach | |
3E0N30M | Introduction of Antineoplastic, Monoclonal Antibody, into Male Reproductive, Percutaneous Approach | |
3E0N32 | Anti-infective | |
3E0N328 | Introduction of Oxazolidinones into Male Reproductive, Percutaneous Approach | |
3E0N329 | Introduction of Other Anti-infective into Male Reproductive, Percutaneous Approach | |
3E0N33 | Anti-inflammatory | |
3E0N33Z | Introduction of Anti-inflammatory into Male Reproductive, Percutaneous Approach | |
3E0N36 | Nutritional Substance | |
3E0N36Z | Introduction of Nutritional Substance into Male Reproductive, Percutaneous Approach | |
3E0N37 | Electrolytic and Water Balance Substance | |
3E0N37Z | Introduction of Electrolytic and Water Balance Substance into Male Reproductive, Percutaneous Approach | |
3E0N3B | Anesthetic Agent | |
3E0N3BZ | Introduction of Anesthetic Agent into Male Reproductive, Percutaneous Approach | |
3E0N3H | Radioactive Substance | |
3E0N3HZ | Introduction of Radioactive Substance into Male Reproductive, Percutaneous Approach | |
3E0N3K | Other Diagnostic Substance | |
3E0N3KZ | Introduction of Other Diagnostic Substance into Male Reproductive, Percutaneous Approach | |
3E0N3N | Analgesics, Hypnotics, Sedatives | |
3E0N3NZ | Introduction of Analgesics, Hypnotics, Sedatives into Male Reproductive, Percutaneous Approach | |
3E0N3T | Destructive Agent | |
3E0N3TZ | Introduction of Destructive Agent into Male Reproductive, Percutaneous Approach | |
3E0N3G | Other Therapeutic Substance | |
3E0N3GC | Introduction of Other Therapeutic Substance into Male Reproductive, Percutaneous Approach | |
3E0N3S | Gas | |
3E0N3SF | Introduction of Other Gas into Male Reproductive, Percutaneous Approach | |
3E0N7 | Via Natural or Artificial Opening | |
3E0N70 | Antineoplastic | |
3E0N704 | Introduction of Liquid Brachytherapy Radioisotope into Male Reproductive, Via Natural or Artificial Opening | |
3E0N705 | Introduction of Other Antineoplastic into Male Reproductive, Via Natural or Artificial Opening | |
3E0N70M | Introduction of Antineoplastic, Monoclonal Antibody, into Male Reproductive, Via Natural or Artificial Opening | |
3E0N72 | Anti-infective | |
3E0N728 | Introduction of Oxazolidinones into Male Reproductive, Via Natural or Artificial Opening | |
3E0N729 | Introduction of Other Anti-infective into Male Reproductive, Via Natural or Artificial Opening | |
3E0N73 | Anti-inflammatory | |
3E0N73Z | Introduction of Anti-inflammatory into Male Reproductive, Via Natural or Artificial Opening | |
3E0N76 | Nutritional Substance | |
3E0N76Z | Introduction of Nutritional Substance into Male Reproductive, Via Natural or Artificial Opening | |
3E0N77 | Electrolytic and Water Balance Substance | |
3E0N77Z | Introduction of Electrolytic and Water Balance Substance into Male Reproductive, Via Natural or Artificial Opening | |
3E0N7B | Anesthetic Agent | |
3E0N7BZ | Introduction of Anesthetic Agent into Male Reproductive, Via Natural or Artificial Opening | |
3E0N7H | Radioactive Substance | |
3E0N7HZ | Introduction of Radioactive Substance into Male Reproductive, Via Natural or Artificial Opening | |
3E0N7K | Other Diagnostic Substance | |
3E0N7KZ | Introduction of Other Diagnostic Substance into Male Reproductive, Via Natural or Artificial Opening | |
3E0N7N | Analgesics, Hypnotics, Sedatives | |
3E0N7NZ | Introduction of Analgesics, Hypnotics, Sedatives into Male Reproductive, Via Natural or Artificial Opening | |
3E0N7T | Destructive Agent | |
3E0N7TZ | Introduction of Destructive Agent into Male Reproductive, Via Natural or Artificial Opening | |
3E0N7G | Other Therapeutic Substance | |
3E0N7GC | Introduction of Other Therapeutic Substance into Male Reproductive, Via Natural or Artificial Opening | |
3E0N7S | Gas | |
3E0N7SF | Introduction of Other Gas into Male Reproductive, Via Natural or Artificial Opening | |
3E0N8 | Via Natural or Artificial Opening Endoscopic | |
3E0N80 | Antineoplastic | |
3E0N804 | Introduction of Liquid Brachytherapy Radioisotope into Male Reproductive, Via Natural or Artificial Opening Endoscopic | |
3E0N805 | Introduction of Other Antineoplastic into Male Reproductive, Via Natural or Artificial Opening Endoscopic | |
3E0N80M | Introduction of Antineoplastic, Monoclonal Antibody, into Male Reproductive, Via Natural or Artificial Opening Endoscopic | |
3E0N82 | Anti-infective | |
3E0N828 | Introduction of Oxazolidinones into Male Reproductive, Via Natural or Artificial Opening Endoscopic | |
3E0N829 | Introduction of Other Anti-infective into Male Reproductive, Via Natural or Artificial Opening Endoscopic | |
3E0N83 | Anti-inflammatory | |
3E0N83Z | Introduction of Anti-inflammatory into Male Reproductive, Via Natural or Artificial Opening Endoscopic | |
3E0N86 | Nutritional Substance | |
3E0N86Z | Introduction of Nutritional Substance into Male Reproductive, Via Natural or Artificial Opening Endoscopic | |
3E0N87 | Electrolytic and Water Balance Substance | |
3E0N87Z | Introduction of Electrolytic and Water Balance Substance into Male Reproductive, Via Natural or Artificial Opening Endoscopic | |
3E0N8B | Anesthetic Agent | |
3E0N8BZ | Introduction of Anesthetic Agent into Male Reproductive, Via Natural or Artificial Opening Endoscopic | |
3E0N8H | Radioactive Substance | |
3E0N8HZ | Introduction of Radioactive Substance into Male Reproductive, Via Natural or Artificial Opening Endoscopic | |
3E0N8K | Other Diagnostic Substance | |
3E0N8KZ | Introduction of Other Diagnostic Substance into Male Reproductive, Via Natural or Artificial Opening Endoscopic | |
3E0N8N | Analgesics, Hypnotics, Sedatives | |
3E0N8NZ | Introduction of Analgesics, Hypnotics, Sedatives into Male Reproductive, Via Natural or Artificial Opening Endoscopic | |
3E0N8T | Destructive Agent | |
3E0N8TZ | Introduction of Destructive Agent into Male Reproductive, Via Natural or Artificial Opening Endoscopic | |
3E0N8G | Other Therapeutic Substance | |
3E0N8GC | Introduction of Other Therapeutic Substance into Male Reproductive, Via Natural or Artificial Opening Endoscopic | |
3E0N8S | Gas | |
3E0N8SF | Introduction of Other Gas into Male Reproductive, Via Natural or Artificial Opening Endoscopic | |
3E0N4 | Percutaneous Endoscopic | |
3E0N4G | Other Therapeutic Substance | |
3E0N4GC | Introduction of Other Therapeutic Substance into Male Reproductive, Percutaneous Endoscopic Approach |
ICD-10-CM-2023 Code Search Engine and PCS-2023 Code Search Engine |